Based on these and considering our findings regarding the possible neuroprotective effect of IGF-I, it would be better to perform a subtotal tumor removal in the more elderly population, when the IGF-I levels are elevated >220 ng/ml, in order to avoid any dysfunction. The gene discussed is IGF1; the disease is neoplasm.